Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Swiss company PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable that integrates the delivery of insulin with continuous glucose monitoring (CGM ...

T he Food and Drug Administration rejected Novo Nordisk’s weekly insulin for the treatment of diabetes in a rare setback for the pharmaceutical giant.. The agency has requests related to the ...

Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take insulin every day to manage their type 2 ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, with nearly 90% of participants losing at least 5% of their body weight.